mesenchymal stem cells / GIOSTAR - LARVOL DELTA

Mesenchymal stem cell therapy for treating the underlying causes of diabetes mellitus and its consequences. (PubMed, Curr Stem Cell Res Ther) - "This review covers the principal mechanisms of action induced during MSC therapy in reference to the described pathophysiological pathways of both T1D and T2D. In addition, how this therapeutic intervention can counteract the ill effects of this condition leading to the promotion of tissue regeneration has been covered."

Journal • Diabetes • Immune Modulation • Immunology • Inflammation • Metabolic Disorders • IL6 • TNFA